Valuation Instituto Rosenbusch S.A.

Stocks

End-of-day quote Buenos Aires S.E. 2026-09-30			5-day change	1st Jan Change
149.00 ^ARS	+2.41%		-3.56%	-38.05%

Sep. 15	Instituto Rosenbusch S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
Aug. 06	Instituto Rosenbusch S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	489.8	468.5	549.4	2,726	5,196	10,243
Change	-	-4.35%	17.27%	396.12%	90.63%	97.13%
Enterprise Value (EV) ¹	597	602.5	787.7	3,369	6,059	10,981
Change	-	0.92%	30.75%	327.65%	79.86%	81.22%
P/E	-28.8x	-23.9x	-67.8x	4.84x	-3.67x	-2.23x
PBR	3.76x	2.65x	1.51x	1.42x	1.83x	-12.8x
PEG	-	-1.6x	1.2x	-0x	0x	-0x
Capitalization / Revenue	0.88x	0.6x	0.4x	0.6x	0.63x	1.6x
EV / Revenue	1.07x	0.77x	0.57x	0.74x	0.73x	1.71x
EV / EBITDA	7.27x	13.5x	2.48x	27.5x	2.98x	-3.46x
EV / EBIT	9.38x	28x	2.95x	213x	3.24x	-3.26x
EV / FCF	7.75x	-15.3x	5.1x	-3.01x	2.12x	6.74x
FCF Yield	12.9%	-6.52%	19.6%	-33.2%	47.2%	14.8%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.3993	-0.4595	-0.1901	13.22	-33.28	-108
Distribution rate	-	-	-	-	-	-
Net sales ¹	558.6	781.6	1,373	4,528	8,275	6,404
EBITDA ¹	82.12	44.7	317.2	122.7	2,031	-3,177
EBIT ¹	63.65	21.55	267.2	15.78	1,871	-3,369
Net income ¹	-17.01	-19.57	-8.098	562.9	-1,417	-4,598
Net Debt ¹	107.2	134	238.3	643.1	863.2	737.7
Reference price ²	11.50	11.00	12.90	64.00	122.00	240.50
Nbr of stocks (in thousands)	42,589	42,589	42,589	42,589	42,589	42,589
Announcement Date	4/5/21	3/13/22	3/20/23	3/27/24	4/7/25	4/9/26

¹ARS in Million²ARS

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
INSTITUTO ROSENBUSCH S.A.	-	-	-	-	4.16M
ELI LILLY AND COMPANY	32.9x	11.93x	24.23x	0.6%	1,031B
JOHNSON & JOHNSON	29.45x	6.54x	18.31x	2.02%	638B
ABBVIE INC.	33.1x	7.75x	16.02x	2.65%	462B
MERCK & CO., INC.	105.72x	5.91x	25.05x	2.35%	359B
ROCHE HOLDING AG	19x	4.63x	11.48x	2.87%	335B
NOVARTIS AG	20.37x	5.28x	13.08x	3.03%	273B
ASTRAZENECA PLC	20.79x	4.31x	12.28x	2.05%	253B
AMGEN INC.	26.62x	6.92x	12.32x	2.39%	228B
GILEAD SCIENCES, INC.	-45.08x	6.57x	25.65x	2.21%	185B
Average	26.98x	6.65x	17.60x	2.24%	376.39B
Weighted average by Cap.	32.10x	7.72x	18.90x	1.92%